Evidence map›Paper›PMID 41017528›Full record

ArticleInternational journal of immunopathology and pharmacology

Flow cytometry-based evaluation of CD4/CD25 and IL-17 expression in sepsis of cancer surgical patients.

Ahmed Samir Abdelhafiz, Asmaa Ali, Walaa Y Elsabeeny, Ahmed Fahmy, Merhan A Fouda, Mahmoud Ali Ayoub, Marwa Hanafi

Abstract read
In one paragraph

Article in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmed Samir AbdelhafizDepartment of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.ORCID 0000-0003-4564-8073
Asmaa AliDepartment of Pulmonary Medicine, Abbassia Chest Hospital, Ministry of Health and Population, Cairo, Egypt.
Walaa Y ElsabeenyDepartment of Anesthesia, Surgical Critical Care and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.
Ahmed FahmyDepartment of Anesthesia, Surgical Critical Care and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.
Merhan A FoudaDepartment of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
Mahmoud Ali AyoubDepartment of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
Marwa HanafiDepartment of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

objectivesSepsis is a critical, life-threatening condition marked by organ dysfunction. Patients undergoing surgery for cancer are especially susceptible, facing a significantly increased risk compared to the general population. Prompt diagnosis is essential for optimal treatment outcomes. This study investigates the expression levels of IL-17 and CD4/CD25 in postoperative surgical oncology patients diagnosed with sepsis and examines their association with various clinicopathological parameters, including mortality.

methodsPeripheral blood samples were collected 48 h following admission to the surgical ICU. Flow cytometry was employed to measure the expression of IL-17 and CD4/CD25 in both septic patients and non-septic controls.

resultsThe study included 30 septic patients and an equal number of controls. The expression of IL-17 and CD4/CD25 was significantly higher in septic patients compared to non-septic patients, demonstrating high diagnostic performance. Additionally, elevated IL-17 expression was strongly associated with an increased risk of mortality.

conclusionOur study provides insight into immune dysregulation in postoperative cancer patients with sepsis, highlighting the dual arms of active inflammation and immunoparalysis. Elevated IL-17 levels, coupled with Treg activation, were linked to poorer outcomes. Therapeutic strategies that target IL-17 signaling and modulate Treg activity may help restore immune balance and improve prognosis in immunocompromised individuals. Furthermore, developing predictive models using machine learning to classify sepsis severity based on immune markers could enhance diagnosis and prognosis.

Indexed as

CD4 AntigensFlow CytometryInterleukin-17Interleukin-2 Receptor alpha SubunitNeoplasmsSepsisAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedT-Lymphocytes, RegulatoryCD4 AntigensIL17A protein, humanIL2RA protein, humanInterleukin-17Interleukin-2 Receptor alpha SubunitCD4/CD25IL-17post-operativesepsisTregs

Identifiers

PMID41017528
PMCPMC12480818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.